Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).
27 Août 2024 - 10:19PM
Edgar (US Regulatory)
August 27, 2024
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
| | | | | |
| Re: | Notice of disclosure filed in Quarterly Report on Form 10-Q under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the U.S. Securities Exchange Act of 1934, as amended |
Ladies and Gentlemen,
Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the U.S. Securities Exchange Act of 1934, as amended, notice is hereby provided that Medtronic plc has made disclosure pursuant to such provisions in its Quarterly Report on Form 10-Q for the period ended July 26, 2024, which was filed with the U.S. Securities and Exchange Commission on August 27, 2024.
Sincerely,
Medtronic plc
| | |
| /s/ Jennifer M. Kirk |
| Jennifer M. Kirk |
| Senior Vice President, Global Controller and Chief Accounting Officer (Principal Accounting Officer) |
Medtronic (NYSE:MDT)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Medtronic (NYSE:MDT)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024
